STAT3 and Miyoshi myopathy: STAT3-activating mutations have been identified in higher frequencies in various hematologic malignancies with a maximum incidence of 40% in large granular lymphocytic lymphoma.12 However, mutations in this gene have been rarely detected in MM and in only 3.5% of our cohort.